CPRX Catalyst Pharmaceuticals, Inc. Stock Quote

CPRX [NASD]

Index	-	P/E	29.68	EPS (ttm)	0.50	Insider Own	7.30%	Shs Outstand	102.80M	Perf Week	7.21%
Market Cap	1.55B	Forward P/E	17.54	EPS next Y	0.85	Insider Trans	-9.90%	Shs Float	94.95M	Perf Month	36.80%
Income	54.50M	PEG	-	EPS next Q	0.19	Inst Own	76.30%	Short Float	7.15%	Perf Quarter	107.39%
Sales	170.50M	P/S	9.12	EPS this Y	-48.10%	Inst Trans	7.05%	Short Ratio	3.18	Perf Half Y	98.80%
Book/sh	2.35	P/B	6.33	EPS next Y	20.80%	ROA	22.40%	Target Price	16.90	Perf Year	186.51%
Cash/sh	2.11	P/C	7.04	EPS next 5Y	-	ROE	25.10%	52W Range	4.81 - 15.07	Perf YTD	119.65%
Dividend	-	P/FCF	-	EPS past 5Y	29.80%	ROI	19.00%	52W High	-0.86%	Beta	1.32
Dividend %	-	Quick Ratio	10.40	Sales past 5Y	-	Gross Margin	84.60%	52W Low	210.60%	ATR	0.80
Employees	76	Current Ratio	10.80	Sales Q/Q	45.90%	Oper. Margin	42.70%	RSI (14)	68.88	Volatility	5.42% 6.26%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	75.00%	Profit Margin	32.00%	Rel Volume	3.05	Prev Close	14.87
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 09 AMC	Payout	0.00%	Avg Volume	2.13M	Price	14.94
Recom	2.00	SMA20	6.82%	SMA50	35.52%	SMA200	83.85%	Volume	1,292,867	Change	0.47%

Aug-24-22

Downgrade

ROTH Capital

Buy → Neutral

$10 → $15.50

Sep-21-18

Initiated

Cantor Fitzgerald

Overweight

Sep-07-18

Resumed

Piper Jaffray

Overweight

Oct-05-16

Upgrade

Piper Jaffray

Neutral → Overweight

Apr-26-16

Downgrade

Piper Jaffray

Overweight → Neutral

$6 → $1

Sep-30-14

Reiterated

ROTH Capital

Buy

$5 → $6

Sep-16-14

Reiterated

ROTH Capital

Buy

$3.50 → $5

Sep-15-14

Reiterated

H.C. Wainwright

Buy

$5 → $13

Oct-21-13

Reiterated

Aegis Capital

Buy

$4 → $5.50

Sep-24-13

Initiated

Maxim Group

Buy

Sep-06-13

Reiterated

Aegis Capital

Buy

$3.50 → $4

Apr-18-13

Initiated

Aegis Capital

Buy

$2.50

Aug-27-12

Upgrade

Rodman & Renshaw

Mkt Perform → Mkt Outperform

$3.70

Oct-01-09

Upgrade

Merriman

Sell → Neutral

May-29-09

Downgrade

Merriman Curhan Ford

Buy → Sell

May-29-09

Downgrade

Hapoalim

Neutral → Underperform

Dec-15-08

Initiated

Merriman Curhan Ford

Buy

Nov-28-07

Initiated

Rodman & Renshaw

Mkt Outperform

Jan-31-07

Initiated

Stifel Nicolaus

Buy

Jan-05-07

Initiated

First Albany

Buy

$10

Sep-05-22 01:46PM	Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following Fundamentals? Simply Wall St.
Aug-26-22 12:45PM	3 Reasons Why Catalyst (CPRX) Is a Great Growth Stock Zacks
12:00PM	Here's Why Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock to Buy Zacks
09:40AM	Has Aerie Pharmaceuticals (AERI) Outpaced Other Medical Stocks This Year? Zacks
08:30AM	If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now Zacks
Aug-24-22 08:03AM	Catalyst Pharmaceuticals To Participate in Citi's 17th Annual BioPharma Conference GlobeNewswire -6.30%
Aug-23-22 10:53AM	Got $2,500? These 2 Small-Cap Monsters Are Crushing Tesla Stock Motley Fool
Aug-09-22 06:35PM	Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Top Estimates Zacks
04:25PM	Catalyst Pharmaceuticals Delivers Strong Second Quarter 2022 Financial Results with Record FIRDAPSE® Revenues and Provides Corporate Update GlobeNewswire
Jul-26-22 08:03AM	Catalyst Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 9, 2022 GlobeNewswire
Jul-14-22 06:01AM	Catalyst (CPRX) Stock Jumps 10%: Will It Continue to Soar? Zacks
Jul-12-22 06:00AM	Catalyst Pharmaceuticals Announces Settlement of U.S. Patent Litigation and Resolution of Litigation Challenging Ruzurgi® Approval with Jacobus Pharmaceutical GlobeNewswire
Jun-25-22 08:15AM	What Type Of Shareholders Own The Most Number of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares? Simply Wall St.
Jun-09-22 11:30AM	Catalyst (CPRX) Up 6.9% Since Last Earnings Report: Can It Continue? Zacks
Jun-04-22 11:07AM	Is Now the Time to Buy This Risky Stock With Huge Upside Potential? Motley Fool
May-17-22 08:03AM	Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences GlobeNewswire
May-11-22 06:05AM	Catalyst Pharmaceuticals (NASDAQ:CPRX) pulls back 10% this week, but still delivers shareholders solid 27% CAGR over 5 years Simply Wall St. -6.06%
May-10-22 05:25PM	Catalyst Pharmaceutical (CPRX) Misses Q1 Earnings and Revenue Estimates Zacks +5.96%
04:11PM	Catalyst Pharmaceuticals Reports Record First Quarter 2022 Financial Results And Provides Corporate Update GlobeNewswire
May-09-22 05:45PM	Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates Zacks -9.42%
Apr-25-22 08:03AM	Catalyst Pharmaceuticals to Report First Quarter 2022 Financial Results on May 10, 2022 GlobeNewswire
Apr-05-22 06:41PM	7 Smart Stocks to Buy Now Under $10 InvestorPlace
Mar-29-22 05:15PM	Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market? Simply Wall St.
Mar-16-22 05:45PM	Catalyst Pharmaceutical (CPRX) Q4 Earnings Lag Estimates Zacks
04:21PM	Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update GlobeNewswire
09:40AM	Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year? Zacks
Mar-11-22 08:03AM	Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce a Second Favorable Canadian Federal Court Ruling Setting Aside Approval of Ruzurgi® GlobeNewswire
Mar-09-22 03:00PM	Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks +6.42%
09:45AM	Assertio (ASRT) Q4 Earnings Lag Estimates Zacks
Mar-08-22 08:03AM	Catalyst Pharmaceuticals Named Among Forbes 2022 America's Best Small Companies GlobeNewswire
Mar-03-22 09:20AM	Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on March 16, 2022 GlobeNewswire
Mar-02-22 08:03AM	Catalyst Pharmaceuticals Further Strengthens FIRDAPSE® U.S. Patent Portfolio GlobeNewswire
Feb-28-22 10:00AM	Wall Street Analysts Predict a 25% Upside in Catalyst (CPRX): Here's What You Should Know Zacks
08:50AM	What Makes Catalyst (CPRX) a Good Fit for "Trend Investing" Zacks
Feb-24-22 08:03AM	Catalyst Pharmaceuticals Teams Up with Patients and Advocacy Groups to Ring Nasdaq Opening Bell on Rare Disease Day 2022 GlobeNewswire
Feb-17-22 08:03AM	Catalyst Pharmaceuticals to Launch LEMS Aware Podcast on Rare Disease Day 2022 GlobeNewswire
Feb-15-22 10:41AM	10 Best Robinhood Stocks To Buy Right Now Insider Monkey
Feb-11-22 08:50AM	Here's Why Momentum in Catalyst (CPRX) Should Keep going Zacks +7.15%
Feb-10-22 10:00AM	Wall Street Analysts See a 33% Upside in Catalyst (CPRX): Can the Stock Really Move This High? Zacks
09:40AM	Is Aravive (ARAV) Outperforming Other Medical Stocks This Year? Zacks
Feb-08-22 09:49AM	Analysts Just Shipped A Substantial Upgrade To Their Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Estimates Simply Wall St. +6.88%
Feb-07-22 08:03AM	Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2021 Total Revenues; Provides 2022 Total Revenue Guidance and Corporate Update GlobeNewswire +16.16%
Feb-03-22 08:03AM	Catalyst Pharmaceuticals Reports that the FDA Marketing Approval Previously Granted for Ruzurgi® is No Longer Valid GlobeNewswire
Jan-28-22 01:46PM	Catalyst Pharmaceuticals Announces Issuance of Mandate by the U.S. Court of Appeals for the 11th Circuit Directing the District Court Judge in Catalyst's Lawsuit Against the FDA to Grant Summary Judgement in Favor of Catalyst GlobeNewswire
Jan-16-22 07:05AM	How Much Of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Do Insiders Own? Simply Wall St.
Jan-10-22 08:03AM	Catalyst Pharmaceuticals Announces 11th Circuit Court of Appeals Denial of Jacobus Pharmaceutical Company Inc.'s Petition for Rehearing GlobeNewswire
Jan-05-22 07:25AM	News in Brief: Renovations begin on First Choice Laboratory's future headquarters; CBG Luxury Team joins Compass American City Business Journals
Jan-04-22 07:30AM	Catalyst Pharmaceuticals to Participate in January 2022 Virtual Investor Conferences GlobeNewswire
Dec-20-21 06:23AM	2 Top Healthcare Stocks Ready for a Bull Run in 2022 Motley Fool
Dec-06-21 07:00AM	Catalyst Pharmaceuticals Announces DyDo Pharma Initiation of a Phase 3 Study for FIRDAPSE® (amifampridine) in Japan GlobeNewswire
Dec-02-21 05:13AM	Even though Catalyst Pharmaceuticals (NASDAQ:CPRX) has lost US$54m market cap in last 7 days, shareholders are still up 513% over 5 years Simply Wall St.
Nov-15-21 04:15PM	Catalyst Pharmaceuticals to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference GlobeNewswire
10:51AM	How Much Upside is Left in Catalyst (CPRX)? Wall Street Analysts Think 30% Zacks
Nov-09-21 06:35PM	Catalyst Pharmaceutical (CPRX) Q3 Earnings Meet Estimates Zacks
04:14PM	Catalyst Pharmaceuticals Reports Third Quarter 2021 Financial Results GlobeNewswire
Nov-04-21 08:50AM	Catalyst (CPRX) Is a Great Choice for "Trend" Investors, Here's Why Zacks
Nov-02-21 03:02PM	Earnings Preview: Catalyst Pharmaceutical (CPRX) Q3 Earnings Expected to Decline Zacks
Oct-25-21 08:03AM	Catalyst Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 9, 2021 GlobeNewswire
Oct-18-21 08:24AM	Is Catalyst Pharmaceuticals, Inc.'s(NASDAQ:CPRX) Recent Stock Performance Tethered To Its Strong Fundamentals? Simply Wall St.
Oct-12-21 08:50AM	What Makes Catalyst (CPRX) a Good Fit for "Trend Investing" Zacks
Oct-08-21 07:21AM	Strength Seen in Catalyst (CPRX): Can Its 6.9% Jump Turn into More Strength? Zacks
Sep-30-21 12:08PM	Catalyst Pharmaceuticals Receives Positive Decision from Appeals Court That Supports Orphan Drug Exclusivity for Firdapse® for LEMS GlobeNewswire +5.58%
Sep-17-21 08:03AM	Catalyst Pharmaceuticals to Participate at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit GlobeNewswire
Sep-10-21 08:03AM	Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences GlobeNewswire
Sep-08-21 11:30AM	Why Is Catalyst (CPRX) Down 12.6% Since Last Earnings Report? Zacks
Aug-16-21 08:03AM	Catalyst Pharmaceuticals Appoints Mary Coleman as Vice President, Head of Investor Relations GlobeNewswire -5.46%
Aug-09-21 06:55PM	Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Top Estimates Zacks
04:39PM	Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire
Aug-02-21 03:01PM	Catalyst Pharmaceutical (CPRX) Reports Next Week: What Awaits? Zacks
Jul-26-21 08:03AM	Catalyst Pharmaceuticals to Hold Second Quarter 2021 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, August 10th, 2021 GlobeNewswire
Jul-23-21 04:03AM	What Type Of Shareholders Own The Most Number of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares? Simply Wall St.
Jul-19-21 08:03AM	Catalyst Pharmaceuticals Announces Issuance of U.S. Patent 11,060,128 a Method of Use Patent with Claims Covering Firdapse® GlobeNewswire
Jul-06-21 08:03AM	Catalyst Pharmaceuticals Expands Leadership Team with Appointment of Preethi Sundaram, Ph.D. as Chief Product Development Officer GlobeNewswire
Jun-29-21 08:03AM	Catalyst Pharmaceuticals Appoints Pharmaceutical Executive Molly Harper to its Board of Directors GlobeNewswire
Jun-28-21 04:30PM	Catalyst Pharmaceuticals Comments on Recent Decision by Health Canada to Re-issue an NOC for Ruzurgi® GlobeNewswire
08:03AM	Catalyst Pharmaceuticals Announces Exclusive License and Supply Agreement with DyDo Pharma for the Development and Commercialization of Firdapse® in Japan GlobeNewswire
Jun-16-21 02:38AM	Did You Miss Catalyst Pharmaceuticals' (NASDAQ:CPRX) Whopping 567% Share Price Gain? Simply Wall St.
Jun-09-21 11:30AM	Catalyst (CPRX) Up 18.6% Since Last Earnings Report: Can It Continue? Zacks
Jun-03-21 03:09PM	Catalyst Pharmaceuticals, Inc.'s and KYE Pharmaceuticals' Lawsuit in Canadian Federal Court Quashes the Notice of Compliance (NOC) for Ruzurgi® CNW Group
01:20PM	Catalyst Pharmaceuticals, Inc.s and KYE Pharmaceuticals Lawsuit in Canadian Federal Court Quashes the Notice of Compliance (NOC) for Ruzurgi® GlobeNewswire
May-19-21 08:03AM	Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences GlobeNewswire
May-11-21 06:30AM	Catalyst Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
03:06AM	Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following Fundamentals? Simply Wall St.
May-10-21 07:05PM	Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings Estimates Zacks
05:29PM	Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
May-08-21 06:12AM	This Under-the-Radar Pharma Company's Recent Success Is Just the Beginning Motley Fool
May-03-21 03:01PM	Earnings Preview: Catalyst Pharmaceutical (CPRX) Q1 Earnings Expected to Decline Zacks +6.33%
08:05AM	Catalyst Pharmaceuticals to Hold First Quarter 2021 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, May 11th, 2021 GlobeNewswire
Apr-14-21 11:30AM	Why Is Catalyst (CPRX) Up 8.9% Since Last Earnings Report? Zacks
Apr-05-21 01:03AM	Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Catapults 28% Though Its Price And Business Still Lag The Market Simply Wall St.
Mar-22-21 08:03AM	Catalyst Pharmaceuticals Announces $40 Million Share Repurchase Program GlobeNewswire +7.32%
Mar-21-21 04:42AM	With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Is Interesting Simply Wall St.
Mar-18-21 06:02PM	Top Biotech Stocks for Q2 2021 Investopedia
Mar-16-21 10:38AM	Catalyst Pharma 4Q Revenue, Earnings Outperform Estimates SmarterAnalyst +5.33%
06:30AM	Catalyst Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-15-21 06:45PM	Catalyst Pharmaceutical (CPRX) Beats Q4 Earnings and Revenue Estimates Zacks
05:26PM	Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update GlobeNewswire
Mar-08-21 12:30PM	Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Mar-04-21 11:00AM	Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 16th, 2021 GlobeNewswire
Feb-22-21 08:03AM	Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2021 GlobeNewswire

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GRANDE ALICIA	VP, Treasurer and CFO	Aug 29	Sale	14.20	57,000	809,560	407,442	Aug 30 05:00 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 26	Sale	14.40	11,095	159,768	464,442	Aug 30 05:00 PM
Daly Richard J	Director	Aug 24	Option Exercise	2.53	40,000	101,200	92,666	Aug 26 05:01 PM
Tierney David S	Director	Aug 22	Option Exercise	2.53	20,000	50,600	328,207	Aug 23 05:01 PM
Tierney David S	Director	Aug 22	Sale	14.16	20,000	283,180	308,207	Aug 23 05:01 PM
MCENANY PATRICK J	President and CEO	Aug 19	Option Exercise	2.53	125,000	316,250	5,055,217	Aug 19 05:02 PM
MCENANY PATRICK J	President and CEO	Aug 19	Sale	14.10	125,000	1,762,425	4,930,217	Aug 19 05:02 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 18	Option Exercise	2.53	19,259	48,725	494,796	Aug 19 05:02 PM
Miller Steve	Chief Operating Officer	Aug 18	Option Exercise	2.53	150,000	379,500	880,299	Aug 19 05:03 PM
O'Keeffe Charles B	Director	Aug 18	Option Exercise	2.53	40,000	101,200	653,042	Aug 19 05:03 PM
MCENANY PATRICK J	President and CEO	Aug 18	Option Exercise	2.53	175,000	442,750	4,980,217	Aug 19 05:02 PM
MCENANY PATRICK J	President and CEO	Aug 18	Sale	13.94	175,000	2,440,350	4,930,217	Aug 19 05:02 PM
Miller Steve	Chief Operating Officer	Aug 18	Sale	13.53	150,000	2,029,922	761,724	Aug 19 05:03 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 18	Sale	13.70	19,259	263,848	475,537	Aug 19 05:02 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 17	Option Exercise	2.53	130,741	330,775	574,853	Aug 19 05:02 PM
COELHO PHILIP H	Director	Aug 17	Option Exercise	2.53	40,000	101,200	279,553	Aug 19 05:02 PM
GRANDE ALICIA	VP, Treasurer and CFO	Aug 17	Sale	13.86	130,741	1,811,635	475,537	Aug 19 05:02 PM
INGENITO GARY	Chief Medical & Reg. Officer	Jun 22	Option Exercise	4.13	6,152	25,408	28,205	Jun 23 05:02 PM
INGENITO GARY	Chief Medical & Reg. Officer	Jun 22	Sale	6.61	6,152	40,646	22,053	Jun 23 05:02 PM
INGENITO GARY	Chief Medical & Reg. Officer	Jun 21	Option Exercise	4.13	143,848	594,092	165,901	Jun 23 05:02 PM
INGENITO GARY	Chief Medical & Reg. Officer	Jun 21	Sale	6.59	143,848	948,678	22,053	Jun 23 05:02 PM
Tierney David S	Director	May 20	Option Exercise	2.53	20,000	50,600	328,207	May 24 04:30 PM
Daly Richard J	Director	Jan 25	Option Exercise	3.35	50,000	167,500	52,666	Jan 26 05:29 PM
DENKHAUS DONALD A	Director	Jan 10	Option Exercise	2.53	40,000	101,200	317,666	Jan 11 06:22 PM
DENKHAUS DONALD A	Director	Jan 05	Option Exercise	3.35	50,000	167,500	277,666	Jan 06 04:50 PM
INGENITO GARY	Chief Medical Officer	Dec 07	Sale	6.99	3,612	25,237	22,053	Dec 08 05:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience